Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Objective We investigated the type-specific high-risk human papillomavirus (HPV) prevalence and distribution according to cervical cytology and age in healthy Korean women. Methods A retrospective cross-sectional study was conducted with 7,014 consecutive subjects undergoing both liquid-based cervical cytology and HPV genotyping test by DNA chip for cervical cancer screening. The type-specific prevalence and distribution of individual high-risk HPV types were assessed according to cervical cytology and age groups ( 30, 30-39, 40-49, 50-59, and ≥60 years old). Results In total, the most common HPV genotype was HPV58 (23.9% of all high-risk HPV-positive subjects), followed by HPV16 (21.8%), HPV52 (16.6%), and HPV18 (11.7%). Regarding cervical cytology and age groups, the proportion of HPV56 strongly increased with the increasing severity of cervical cytology (P for trend=0.041). An age-specific decline in the overall high-risk HPV prevalence was reaffirmed, and the proportion of HPV52 declined markedly with age (P for trend=0.014). Conclusion The type-specific prevalence of high-risk HPV types significantly varies according to cervical cytology and age. It may imply that these types have different to develop into precancerous lesions in normal cervix.
Abstract
Objective We investigated the type-specific high-risk human papillomavirus (HPV) prevalence and distribution according to cervical cytology and age in healthy Korean women. Methods A retrospective cross-sectional study was conducted with 7,014 consecutive subjects undergoing both liquid-based cervical cytology and HPV genotyping test by DNA chip for cervical cancer screening. The type-specific prevalence and distribution of individual high-risk HPV types were assessed according to cervical cytology and age groups ( 30, 30-39, 40-49, 50-59, and ≥60 years old). Results In total, the most common HPV genotype was HPV58 (23.9% of all high-risk HPV-positive subjects), followed by HPV16 (21.8%), HPV52 (16.6%), and HPV18 (11.7%). Regarding cervical cytology and age groups, the proportion of HPV56 strongly increased with the increasing severity of cervical cytology (P for trend=0.041). An age-specific decline in the overall high-risk HPV prevalence was reaffirmed, and the proportion of HPV52 declined markedly with age (P for trend=0.014). Conclusion The type-specific prevalence of high-risk HPV types significantly varies according to cervical cytology and age. It may imply that these types have different to develop into precancerous lesions in normal cervix.
참고문헌 (40)
- Wright TC Jr, "Adding a test for human papillomavirus DNA to cervical-cancer screening", N Engl J Med, 348, pp.489~490 (2003)
- Wright TC Jr, "Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening", Obstet Gynecol, 103, pp.304~309 (2004)
- Cuzick J, "Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries", Vaccine, 26(Suppl 10), pp.K29~K41 (2008)
- Meijer CJ, "Clinical utility of HPV genotyping", Gynecol Oncol, 103, pp.12~17 (2006)
- Huh W, "What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?", Gynecol Oncol, 117, pp.481~485 (2010)
- Clifford G, "Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases", Vaccine, 24(Suppl 3), pp.26~34 (2006)
- Smith JS, "Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update", Int J Cancer, 121, pp.621~632 (2007)
- Naucler P, "HPV type-specific risks of high-grade CIN during 4 years of follow-up : a population-based prospective study", Br J Cancer, 97, pp.129~132 (2007)
- Clifford GM, "Human papillomavirus genotype distribution in low-grade cervical lesions : comparison by geographic region and with cervical cancer", Cancer Epidemiol Biomarkers Prev, 14, pp.1157~1164 (2005)
- Wheeler CM, "Human papillomavirus genotype distributions : implications for vaccination and cancer screening in the United States", J Natl Cancer Inst, 101, pp.475~487 (2009)
- Oh JK, "Type-specific human papillomavirus distribution in invasive cervical cancer in Korea, 1958-2004", Asian Pac J Cancer Prev, 11, pp.993~1000 (2010)
- Bae, Jeong-Hoon, "Human Papillomavirus (HPV) Type Distribution in Korean Women: A Meta-Analysis", Journal of Microbiology and Biotechnology, 18(4), pp.788~794 (2008), 한국미생물·생명공학회
- Lee HS, "Human papillomavirus genotyping using HPV DNA chip analysis in Korean women", Int J Gynecol Cancer, 17, pp.497~501 (2007)
- Monsonego J, "Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines", Vaccine, 30, pp.5215~5221 (2012)
- Rhee JE, "Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development", Virol J, 7, pp.201~ (2010)
- Shin HR, "Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea", J Infect Dis, 190, pp.468~476 (2004)
- Kim KH, "Development and evaluation of a highly sensitive human papillomavirus genotyping DNA chip", Gynecol Oncol, 100, pp.38~43 (2006)
- 최유덕, "Analysis of HPV-other Samples by Performing HPV DNA Sequencing", Journal of Pathology and Translational Medicine, 43(3), pp.250~253 (2009), 대한병리학회
- Munoz N, "Against which human papillomavirus types shall we vaccinate and screen? The international perspective", Int J Cancer, 111, pp.278~285 (2004)
- Solomon D, "The 2001 Bethesda System: terminology for reporting results of cervical cytology", JAMA, 287, pp.2114~2119 (2002)
- Castle PE, "The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer", Obstet Gynecol, 116, pp.76~84 (2010)
- Apgar BS, "Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology", Am Fam Physician, 80, pp.147~155 (2009)
- Trottier H, "Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women", Cancer Epidemiol Biomarkers Prev, 18, pp.854~862 (2009)
- Clifford GM, "Human papillomavirus types in invasive cervical cancer worldwide : a meta-analysis", Br J Cancer, 88, pp.63~73 (2003)
- Clifford GM, "Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer : a meta-analysis", Br J Cancer, 89, pp.101~105 (2003)
- 최순호, "자궁경부의 인유두종바이러스 아형의 분석과 HP DNA chip 검사의 임상적 유용성", Obstetrics & Gynecology Science, 50(3), pp.465~475 (2007), 대한산부인과학회
- Lee GY, "Human papillomavirus(HPV)genotyping by HPV DNA chip in cervical cancer and precancerous lesions", Int J Gynecol Cancer, 15, pp.81~87 (2005)
- de Sanjose S, "Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis", Lancet Infect Dis, 7, pp.453~459 (2007)
- Sargent A, "Prevalence of type-specific HPV infection by age and grade of cervical cytology : data from the ARTISTIC trial", Br J Cancer, 98, pp.1704~1709 (2008)
- Kjaer SK, "type-and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark", Int J Cancer, 123, pp.1864~1870 (2008)
- Baandrup L, "HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3", Gynecol Oncol, 124, pp.281~285 (2012)
- Porras C, "Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women", Cancer Epidemiol Biomarkers Prev, 18, pp.863~865 (2009)
- Lee JK, "Comparison of human papillomavirus detection and typing by hybrid capture 2, linear array, DNA chip, and cycle sequencing in cervical swab samples", Int J Gynecol Cancer, 19, pp.266~272 (2009)
- Smits HL, "Intermethod variation in detection of human papillomavirus DNA in cervical smears", J Clin Microbiol, 33, pp.2631~2636 (1995)
- Kim CJ, "HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions", Gynecol Oncol, 89, pp.210~217 (2003)
- Vaucel E, "Human papillomavirus genotype distribution in cervical samples collected in routine clinical practice at the Nantes University Hospital, France", Arch Gynecol Obstet, 284, pp.989~998 (2011)
- Mateos Lindemann ML, "Prevalence and distribution of high-risk genotypes of HPV in women with severe cervical lesions in Madrid, Spain: importance of detecting genotype 16 and other high-risk genotypes", Adv Prev Med, 2011, pp.269468~ (2011)
- Paavonen J, "Efficacy of human papillomavirus (HPV)-16", 18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women, 2009, pp.374, 301~314
- Goldhaber-Fiebert JD, "Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination", Popul Health Metr, 5, pp.11~ (2007)
- Jit M, "Estimating progression rates for human papillomavirus infection from epidemiological data", Med Decis Making, 30, pp.84~98 (2010)